MRK · News · 20261107N

Regulatory Approval Milestones

Merck & Co., Inc. · 2026-11-07 · Importance 17 · Surprise 24

The FDA set an April 22, 2027, target action date for two supplemental IDVYNSO applications. The reported date identifies the expected timing of the agency’s action on both applications. The digest does not quantify a financial impact.

Key facts

• The FDA set April 22, 2027, as the target action date for two supplemental IDVYNSO applications. source